Capital Flow Monitor · Sponsors · CIK 2090779
Rinascera Therapeutics, Inc.
75 KNEELAND ST FL 14, BOSTON, MA, 02111 · (408) 396-3123
Biotechnology · Corporation· inc. DELAWARE true 2025
Fit score
—
Offering
$2.5M
Sold
$2.5M
% sold
100.0%
Investors
3
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-10-08 | D ·current | 506(b) | $2.5M | $2.5M | 100.0% | 3 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
-
Nichola Eliovits — Executive Officer / Director, BOSTON, MA
9 other raises
- OT YC Fund IV, LLC $6.0M of —
- OT AI Infrastructure Fund I, LLC $7.5M of —
- OT AI Cyber Fund I, LLC $376K of —
- OT Robotics Fund I, LLC $6.0M of —
- OT Healthcare Fund III, LLC $2.0M of —
- Maverick Labs, Inc. $15.6M of $20.3M · 76.8%
- Phoenix Tailings, Inc. $106.6M of $106.6M · 100.0%
- OT Quantum Fund I, LLC $1.5M of —
- OT Materials Fund II, LLC $4.9M of —
- Max Dawson — Executive Officer, BOSTON, MA
- Karl Beutner — Executive Officer / Director, BOSTON, MA
- Daniel Yadegar — Director, BOSTON, MA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.